Postoperative radiotherapy after extrapleural pneumonectomy of malignant pleural mesothelioma was investigated in the randomized phase II trial SAKK17/04. The relapse rate within the high and/or low-dose PTV without previous distant failure was 24%, the isolated in-field-relapse rate within the PTVs was 5% and the distant relapse rate outside of the PTVs was 81%. Clinical outcome was mainly determined by distant disease progression outside of the radiation field.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.radonc.2019.05.024 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!